Very small embryonic‐like stem cells (VSELs) are a Sca‐1+ Lin‐CD45‐cell population that
has been isolated from the bone marrow of mice. The similarities and differences between …

The aim of this nonrandomized, open label, phase 1 clinical trial was to evaluate the safety
and the feasibility of the treatment with autologous bone marrow–derived endothelial …

Current treatment options for hepatocellular carcinoma (HCC) are often limited by the
presence of underlying liver disease. In patients with liver cirrhosis, surgery, chemotherapy …

Background We have recently completed an evaluation of the safety and feasibility of
intravenous delivery of autologous bone marrow in patients with progressive multiple …

AIM: To determine the long-term efficacy of autologous bone marrow mononuclear cells (BM-
MNCs) transplantation in terms of improving liver function and reducing complications in …

Introduction Liver disease mortality and morbidity are rapidly rising and liver transplantation
is limited by organ availability. Small scale human studies have shown that stem cell therapy …

AIM To evaluate the therapeutic effects of bone marrow-derived CD11b+ CD14+ monocytes
in a murine model of chronic liver damage. METHODS Chronic liver damage was induced in …

Abstract Background and Aims: Although autologous bone marrow stem cell (BMSC)
transplantation is an effective treatment for liver cirrhosis, there are few reports describing …

Hepatocellular carcinoma (HCC) is a major health problem worldwide, especially for
patients who are suffering from end-stage liver disease (ESLD). The ESLD is considered a …

Portal hypertension (PH) is responsible for the most severe complications of cirrhosis and
leading cause of death and liver transplantation. The standard pharmacological treatment …